CA21967-1A - 0x0000000000003100

Study Number: CA21967
Group Number: 1A
Study Requirement: Healthy Normal Male
Stipend: up to £ 1,000

Study Criteria:

  • Age: 18 - 50
  • BMI: 0 - 0
  • Weight Restriction: minimum weight 0 lbs

Study Information:

  • Indication: This investigational medication is being developed to treat Cystic Fibrosis.
  • Route of Administration: Inhalation
  • Blood Draws: 10

Study Schedule:

  • Schedule Type: Short Term
  • Study Length: One - 2 Night Stay, 1 Return & 2 Phone Calls

Screening Dates:

Event Day Event Date Site
No search results

Doctor Exam Dates:

Event Day Event Date Site
No search results

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Monday Oct 16 2017 1:00PM Wednesday Oct 18 2017 5:30PM 1 Belfast
Return Tuesday Oct 17 2017 3:30PM Tuesday Oct 17 2017 4:30PM CC1 Belfast
Phone participant* Friday Oct 20 2017 9:00AM 1 Belfast
Phone participant* Sunday Oct 22 2017 9:00AM 1 Belfast
Return Tuesday Oct 24 2017 8:00AM Tuesday Oct 24 2017 11:30AM 1 Belfast